Insights from 2024 SGO Annual Meeting
P

SGO 2024 Insights: "COMB1NE Study - Characteristics and Real-World Outcomes of Epithelial Ovarian Cancer Patients Who Received Niraparib + Bevacizumab 1L Maintenance Therapy"

By Insights from 2024 SGO Annual Meeting FEATURING Premal Thaker
By Insights from 2024 SGO Annual Meeting FEATURING Premal Thaker
159 views
April 30, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

17:33
AstraZeneca Oncology

First-line Maintenance Therapy for BRCAm Advanced Ovarian Cancer Fol…

Feat. S. Lewin

Featured Video

23:14
AstraZeneca Oncology

Management Strategies for Nausea and Vomiting in First-line Maintena…

Feat. D. Czel, C. Arn

Related Content

AUTOPLAY
27:04
Fengting Yan

Cancer Screening Molecular Tools

17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
09:55
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future H…

Feat. E. Hamilton
11:15
Total Health

2024 Updates in Ovarian Cancer

Feat. T. Tillmanns
06:07
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "Key Updates in Gynecological Cancers"

Feat. M. Raza Mirza
04:43
Treatment Approach for Advanced Ovarian Cancer

The Role Of Folate Receptor Alpha In Ovarian Cancer

Feat. D. M. O'Malley
15:45
Michael Birrer

Defining Platinum Resistance in Ovarian Cancer

14:45
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Gynecological Cancers Highlights"

Feat. M. Raza Mirza
06:50
Fengting Yan

Year in Review: Ovarian Cancer

15:14
Brian Slomovitz

Update in Vulvar and Vaginal Cancer

25:10
Yale School of Medicine

Ovarian Cancer Prevention and Early Detection - Ovarian Cancer Does …

Feat. M. Minkin, E. Ratner
06:23
Total Health

Recent Highlights in Ovarian Cancer

Feat. B. Slomovitz
18:16
Insights from 2024 ESGO Annual Meeting

ESGO 2024 Insights: "Antibody-Drug Conjugates in Ovarian Cancer…

Feat. J. Kurtz
27:14
David Tan

Management of Recurrent Ovarian Clear Cell Carcinoma

28:11
OncoAlert

Ovarian Cancer: Setting a New Standard of Care

Feat. M. Raza Mirza
05:20
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Impact of Immune Checkpoint Inhibition on…

Feat. E. Buchbinder
05:09
Insights from 2024 SGO Annual Meeting

SGO 2024 Insights: "Final OS Data of Relacorilant, a Selective …

Feat. N. Colombo
05:32
Insights from 2023 ESMO Asia Annual Meeting

LARA Trial: Preliminary Efficacy of Pembro + Lenvatinib in Recurrent…

Feat. N. Ngoi
17:20
UCLA Health

Antibody Drug Conjugates in Gynecologic Oncology: From Bench to Beds…

Feat. G. Konecny
01:41
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Unveiling the Unique Identity of Clear-Cel…

Feat. F. Blanc-Durand